orfiril 100 mg/ml injektionsvæske, opløsning
orifarm a/s - natriumvalproat - injektionsvæske, opløsning - 100 mg/ml
duoplavin
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotiske midler - duoplavin er indiceret til sekundær forebyggelse af atherotrombotiske hændelser hos voksne patienter, der allerede tager både clopidogrel og acetylsalicylsyre (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. for yderligere oplysninger henvises der til afsnit 5.
orfiril 300 mg enterotabletter
desitin arzneimittel gmbh - natriumvalproat - enterotabletter - 300 mg
orfiril 600 mg enterotabletter
orifarm a/s - natriumvalproat - enterotabletter - 600 mg
orfiril 60 mg/ml oral opløsning
desitin arzneimittel gmbh - natriumvalproat - oral opløsning - 60 mg/ml
orfiril retard 300 mg depottabletter
orifarm a/s - natriumvalproat - depottabletter - 300 mg
depakine chrono 500 mg depottabletter
orifarm a/s - natriumvalproat, valproinsyre - depottabletter - 500 mg
orfiril retard 300 mg depottabletter
desitin arzneimittel gmbh - natriumvalproat - depottabletter - 300 mg
orfiril long 500 mg depotgranulat
desitin arzneimittel gmbh - natriumvalproat - depotgranulat - 500 mg
orfiril long 150 mg depotkapsler, hårde
desitin arzneimittel gmbh - natriumvalproat - depotkapsler, hårde - 150 mg